Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

Multiple studies in the first decade of the 21st century have established contrast‐enhanced
breast MRI as a screening modality for women with a hereditary or familial increased risk for …

Triple-negative breast cancer (TNBC) is a kind of breast cancer that lacks estrogen,
progesterone, and human epidermal growth factor receptor 2. This cancer is responsible for …

In the United States in 2017, an estimated 255,180 new breast cancer cases will be
diagnosed. 1 In 2013, breast cancer deaths totaled 773,100 person-years of life lost, with …

Digital breast tomosynthesis (DBT) has been widely implemented in place of 2D
mammography, although it is less effective in women with extremely dense breasts. Breast …

Importance Younger women (aged≤ 50 years) who underwent breast conservation therapy
may benefit from breast magnetic resonance imaging (MRI) screening as an adjunct to …

Background: Screening MRI is recommended for individuals at high risk for breast cancer,
based on genetic risk or family history (GFH); however, there is insufficient evidence to …

Background Screening programmes utilising blood-based multi-cancer early detection
(MCED) tests, which can detect a shared cancer signal from any site in the body with a …

Background Few studies have compared abbreviated breast MRI with full-protocol MRI in
women with a personal history of breast cancer (PHBC), and they have not adjusted for …

Background Background parenchymal enhancement (BPE) is a known risk factor for breast
cancer. However, studies on the association between BPE and second breast cancer risk …